Scott Akamine - Net Worth and Insider Trading
Scott Akamine Net Worth
The estimated net worth of Scott Akamine is at least $325,376 dollars as of 2024-11-05. Scott Akamine is the Chief Legal Officer of Cerevel Therapeutics Holdings Inc and owns about 7,237 shares of Cerevel Therapeutics Holdings Inc (CERE) stock worth over $325,376. Details can be seen in Scott Akamine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott Akamine has not made any transactions after 2023-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Scott Akamine
Scott Akamine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott Akamine owns 1 companies in total, including Cerevel Therapeutics Holdings Inc (CERE) .
Click here to see the complete history of Scott Akamine’s form 4 insider trades.
Insider Ownership Summary of Scott Akamine
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CERE | Cerevel Therapeutics Holdings Inc | 2023-12-20 | Chief Legal Officer |
Scott Akamine Latest Holdings Summary
Scott Akamine currently owns a total of 1 stock. Scott Akamine owns 7,237 shares of Cerevel Therapeutics Holdings Inc (CERE) as of December 20, 2023, with a value of $325,376.
Latest Holdings of Scott Akamine
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CERE | Cerevel Therapeutics Holdings Inc | 2023-12-20 | 7,237 | 44.96 | 325,376 |
Holding Weightings of Scott Akamine
Scott Akamine Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott Akamine has made a total of 3 transactions in Cerevel Therapeutics Holdings Inc (CERE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Cerevel Therapeutics Holdings Inc is the sale of 7,072 shares on December 20, 2023, which brought Scott Akamine around $292,922.
Insider Trading History of Scott Akamine
- 1
Scott Akamine Trading Performance
Scott Akamine Ownership Network
Ownership Network List of Scott Akamine
Ownership Network Relation of Scott Akamine
Scott Akamine Owned Company Details
What does Cerevel Therapeutics Holdings Inc do?
Who are the key executives at Cerevel Therapeutics Holdings Inc?
Scott Akamine is the Chief Legal Officer of Cerevel Therapeutics Holdings Inc. Other key executives at Cerevel Therapeutics Holdings Inc include director & See Remarks N Anthony Coles , Chief Scientific Officer John Renger , and Chief Medical Officer Ramiro Sanchez .
Cerevel Therapeutics Holdings Inc (CERE) Insider Trades Summary
Over the past 18 months, Scott Akamine made 2 insider transaction in Cerevel Therapeutics Holdings Inc (CERE) with a net sale of 24,572. Other recent insider transactions involving Cerevel Therapeutics Holdings Inc (CERE) include a net sale of 627,506 shares made by N Anthony Coles , a net sale of 37,652 shares made by Ramiro Sanchez , and a net sale of 14,256 shares made by Kenneth Dipietro .
In summary, during the past 3 months, insiders sold 0 shares of Cerevel Therapeutics Holdings Inc (CERE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 966,157 shares of Cerevel Therapeutics Holdings Inc (CERE) were sold and 17,422,701 shares were bought by its insiders, resulting in a net purchase of 16,456,544 shares.
Cerevel Therapeutics Holdings Inc (CERE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cerevel Therapeutics Holdings Inc Insider Transactions
Scott Akamine Mailing Address
Above is the net worth, insider trading, and ownership report for Scott Akamine. You might contact Scott Akamine via mailing address: C/o Aeon Biopharma, Inc., 4040 Macarthur Blvd., Suite 260, Newport Beach Ca 92660.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
